Elaine Tuomanen

Dr. Elaine Tuomanen

orcid

Research Focus & Metrics

Academic Career Length

47Years (1980-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 1995 in Cell
Verified
Journal Article
Open access
WSWilliam C Sha
William C Sha
HLHsiou-Chi Liou
Hsiou-Chi Liou
ETElaine Tuomanen
Elaine Tuomanen
DBDavid Baltimore
David Baltimore
NF-kappa B, a heterodimeric transcription factor composed of p50 and p65 subunits, can be activated in many cell types and is thought to regulate a wide variety of genes involved in immune function and development. Mice lacking the p50 subunit of NF-kappa B show no developmental abnormalities, but exhibit multifocal defects in immune responses involving B lymphocytes and nonspecific responses to infection. B cells do not proliferate in response to bacterial lipopolysaccharide and are defective in basal and specific antibody production. Mice lacking p50 are unable effectively to clear L. monocytogenes and are more susceptible to infection with S. pneumoniae, but are more resistant to infection with murine encephalomyocarditis virus. These data support the role of NF-kappa B as a vital transcription factor for both specific and nonspecific immune responses, but do not indicate a developmental role for the factor.

1 October 1995 in Nature
Verified
Journal Article
Closed access
DCDiana R. Cundell
Diana R. Cundell
NGNorma P. Gerard
Norma P. Gerard
CGCraig Gerard
Craig Gerard
IIIlona Idanpaan-Heikkila
Ilona Idanpaan-Heikkila
ETElaine Tuomanen
Elaine Tuomanen

2 November 2008 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
KKKarim C El Kasmi
Karim C El Kasmi
JQJoseph E Qualls
Joseph E Qualls
JPJohn T Pesce
John T Pesce
ASAmber M Smith
Amber M Smith
RTRobert W Thompson
Robert W Thompson
PMPeter J Murray
Peter J Murray

1 July 2013 in Cold Spring Harbor Perspectives in Medicine
Verified
Journal Article
Closed access
PDF file
BHBirgitta Henriques-Normark
Birgitta Henriques-Normark
ETElaine Tuomanen
Elaine Tuomanen
The pneumococcus is the classic Gram-positive extracellular pathogen. The medical burden of diseases it causes is amongst the greatest in the world. Intense study for more than 100 years has yielded an understanding of fundamental aspects of its physiology, pathogenesis, and immunity. Efforts to control infection have led to the deployment of polysaccharide vaccines and an understanding of antibiotic resistance. The inflammatory response to pneumococci, one of the most potent in medicine, has revealed the double-edged sword of clearance of infection but at a cost of damage to host cells. In virtually every aspect of the infectious process, the pneumococcus has set the rules of the Gram-positive pathogenesis game.

1 May 1986 in Microbiology
Verified
Journal Article
Closed access
ETElaine Tuomanen
Elaine Tuomanen
RCR. Cozens
R. Cozens
WTW Tosch
W Tosch
OZO. Zak
O. Zak
ATA. Tomasz
A. Tomasz
Nongrowing bacteria evade the bactericidal activity of beta-lactam antibiotics. We sought to determine if slow growth rate also alters bactericidal activity. The bactericidal activity of two beta-lactams on Escherichia coli grown in glucose limited chemostats was compared for generation times ranging from 0.7 to 12 h. The degree of killing varied with drug structure and with E. coli strain. However, all killing rates were a constant function of the bacterial generation time: slowly growing bacteria became progressively more phenotypically tolerant to beta-lactam antibiotics as the generation time was extended.

1 September 2000 in Cell
Verified
Journal Article
Closed access
JZJing-Ren Zhang
Jing-Ren Zhang
KMKeith E Mostov
Keith E Mostov
MLMichael E Lamm
Michael E Lamm
MNMasanobu Nanno
Masanobu Nanno
SSShin-Ichiro Shimida
Shin-Ichiro Shimida
ETElaine Tuomanen
Elaine Tuomanen